DP VI Associates, L.P.
SEC-identified person · CIK 1298034 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Tranzyme INC TZYM | Officer | filed 2013 - 2017 |
| Tobira Therapeutics, Inc. TBRA | Officer | filed 2013 - 2016 |
| Colucid Pharmaceuticals, Inc. CLCD | Director | filed 2015 - 2016 |
| Syndax Pharmaceuticals Inc SNDX | Director | filed 2016 - 2016 |
| Marinus Pharmaceuticals, INC. NASDAQMRNS | Officer | filed 2014 - 2014 |
| Aldeyra Therapeutics, Inc. ALDX | Officer | filed 2014 - 2014 |
| Cadence Pharmaceuticals INC CADX | Officer | filed 2006 - 2014 |
| Alimera Sciences INC ALM | Officer | filed 2010 - 2014 |
| Celator Pharmaceuticals Inc CPXX | Officer | filed 2013 - 2013 |
| Zogenix, INC. ZGNX | Officer | filed 2010 - 2010 |
| Somaxon Pharmaceuticals, Inc. somx | Officer | filed 2006 - 2006 |
| Vanda Pharmaceuticals Inc. VNDA | Officer | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.